Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Middle Ear Ventilation | 1 | 2023 | 99 | 0.830 |
Why?
|
| Otitis Media with Effusion | 1 | 2023 | 114 | 0.820 |
Why?
|
| Mandibular Fractures | 1 | 2016 | 76 | 0.500 |
Why?
|
| Paranasal Sinuses | 1 | 2017 | 264 | 0.470 |
Why?
|
| Larynx | 2 | 2017 | 492 | 0.470 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2013 | 37 | 0.440 |
Why?
|
| Online Systems | 1 | 2014 | 181 | 0.440 |
Why?
|
| Foreign Bodies | 1 | 2017 | 397 | 0.420 |
Why?
|
| Airway Obstruction | 1 | 2017 | 659 | 0.390 |
Why?
|
| Urology | 1 | 2017 | 424 | 0.390 |
Why?
|
| Otolaryngology | 2 | 2020 | 685 | 0.390 |
Why?
|
| Bronchoscopy | 1 | 2017 | 902 | 0.370 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 1267 | 0.300 |
Why?
|
| Bacteria | 1 | 2017 | 2188 | 0.260 |
Why?
|
| Physicians, Women | 2 | 2020 | 491 | 0.240 |
Why?
|
| Brain Concussion | 1 | 2016 | 1387 | 0.240 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3449 | 0.190 |
Why?
|
| Sexual Harassment | 1 | 2020 | 80 | 0.170 |
Why?
|
| Lung | 1 | 2017 | 9982 | 0.150 |
Why?
|
| Neck | 2 | 2020 | 730 | 0.150 |
Why?
|
| Maxillofacial Injuries | 1 | 2016 | 32 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2023 | 1274 | 0.140 |
Why?
|
| Awards and Prizes | 1 | 2020 | 359 | 0.130 |
Why?
|
| Retropharyngeal Abscess | 1 | 2016 | 21 | 0.130 |
Why?
|
| Mediastinal Diseases | 1 | 2016 | 91 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 4 | 2009 | 4409 | 0.120 |
Why?
|
| Head | 1 | 2020 | 921 | 0.120 |
Why?
|
| Pathology, Clinical | 1 | 1998 | 375 | 0.110 |
Why?
|
| Workplace | 1 | 2020 | 854 | 0.110 |
Why?
|
| Age Distribution | 2 | 2017 | 2892 | 0.110 |
Why?
|
| Phospholipids | 2 | 2009 | 788 | 0.110 |
Why?
|
| Nuclear Proteins | 4 | 2009 | 5793 | 0.100 |
Why?
|
| SEER Program | 2 | 1995 | 1531 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2023 | 1939 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2023 | 2500 | 0.090 |
Why?
|
| Huntington Disease | 2 | 2009 | 1140 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 694 | 0.090 |
Why?
|
| Hypotension | 1 | 2016 | 882 | 0.090 |
Why?
|
| Laryngostenosis | 1 | 2011 | 167 | 0.080 |
Why?
|
| Tracheal Stenosis | 1 | 2011 | 226 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2017 | 1272 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 1185 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1461 | 0.080 |
Why?
|
| Child | 6 | 2023 | 79623 | 0.080 |
Why?
|
| Sex Distribution | 3 | 2020 | 2294 | 0.080 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 1266 | 0.080 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2009 | 251 | 0.070 |
Why?
|
| Stomach Neoplasms | 1 | 1998 | 1422 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2009 | 492 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 951 | 0.070 |
Why?
|
| Endosomes | 1 | 2009 | 519 | 0.070 |
Why?
|
| Students | 1 | 2016 | 1718 | 0.070 |
Why?
|
| Athletic Injuries | 1 | 2016 | 1194 | 0.070 |
Why?
|
| Trachea | 1 | 2011 | 1082 | 0.060 |
Why?
|
| Endocytosis | 1 | 2009 | 960 | 0.060 |
Why?
|
| Cathepsins | 1 | 2006 | 242 | 0.060 |
Why?
|
| Incidence | 4 | 2016 | 21336 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 623 | 0.050 |
Why?
|
| Infant | 5 | 2017 | 35941 | 0.050 |
Why?
|
| Internet | 1 | 2014 | 3073 | 0.050 |
Why?
|
| Clinical Protocols | 2 | 1998 | 1438 | 0.050 |
Why?
|
| Humans | 17 | 2023 | 759255 | 0.050 |
Why?
|
| Adolescent | 5 | 2017 | 87560 | 0.050 |
Why?
|
| Lysosomes | 1 | 2006 | 917 | 0.040 |
Why?
|
| Young Adult | 2 | 2017 | 58483 | 0.040 |
Why?
|
| Peptides | 2 | 2009 | 4357 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2017 | 41935 | 0.040 |
Why?
|
| Male | 9 | 2020 | 358719 | 0.040 |
Why?
|
| Physician Executives | 1 | 2020 | 133 | 0.040 |
Why?
|
| United States | 6 | 2020 | 72237 | 0.040 |
Why?
|
| Female | 9 | 2020 | 390240 | 0.040 |
Why?
|
| Faculty | 1 | 2020 | 382 | 0.040 |
Why?
|
| Adult | 6 | 2020 | 219390 | 0.030 |
Why?
|
| Transferrin | 2 | 2009 | 284 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 2009 | 871 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2020 | 80121 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 642 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3683 | 0.030 |
Why?
|
| Quality Control | 1 | 1998 | 827 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 219653 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 7788 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 20461 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2006 | 5120 | 0.030 |
Why?
|
| Universities | 1 | 2016 | 980 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 58867 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 54204 | 0.020 |
Why?
|
| Leadership | 1 | 2020 | 1368 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2009 | 2651 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 168617 | 0.020 |
Why?
|
| Cardiolipins | 1 | 2009 | 81 | 0.020 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2009 | 67 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 74167 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 3800 | 0.020 |
Why?
|
| Biotin | 1 | 2009 | 253 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2009 | 291 | 0.020 |
Why?
|
| Cartilage | 1 | 2011 | 806 | 0.020 |
Why?
|
| Prognosis | 3 | 1998 | 29561 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2009 | 863 | 0.020 |
Why?
|
| Device Removal | 1 | 2011 | 635 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36160 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2006 | 107 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2006 | 59 | 0.020 |
Why?
|
| Biopsy | 1 | 1998 | 6772 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2005 | 97 | 0.020 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2005 | 124 | 0.020 |
Why?
|
| Protein Binding | 2 | 2009 | 9334 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1090 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 9528 | 0.020 |
Why?
|
| Static Electricity | 1 | 2005 | 261 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 531 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2006 | 311 | 0.010 |
Why?
|
| Protein Transport | 1 | 2009 | 1966 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2009 | 18968 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3604 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 565 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2005 | 383 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 877 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1997 | 4025 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1993 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 6311 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2020 | 5861 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2866 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2006 | 1232 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 1135 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 21981 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 4084 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 2222 | 0.010 |
Why?
|
| Mutation | 3 | 2009 | 29877 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1997 | 6853 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5039 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5783 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 6053 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 3732 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 5427 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3724 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13456 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9466 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 17629 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11058 | 0.010 |
Why?
|
| World Health Organization | 1 | 1997 | 1317 | 0.010 |
Why?
|
| Software | 1 | 2005 | 4421 | 0.010 |
Why?
|
| Animals | 3 | 2009 | 167838 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 81138 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39216 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16871 | 0.000 |
Why?
|
| Neurons | 1 | 2006 | 9411 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1997 | 3489 | 0.000 |
Why?
|
| Neoplasms | 1 | 1995 | 22019 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2011 | 64879 | 0.000 |
Why?
|
| Survival Rate | 1 | 1997 | 12800 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 11123 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 1997 | 7460 | 0.000 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_